The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
The Systemic Inflammation Index on Admission Predicts In-Hospital Mortality in COVID-19 Patients
Open accessAbstract
Background. The rapid onset of a systemic pro-inflammatory state followed by acute respiratory distress syndrome is the leading cause of mortality in patients with COVID-19. We performed a retrospective observational study to explore the capacity of different complete blood cell count (CBC)-derived inflammation indexes to predict in-hospital mortality in this group. Methods. The neutrophil to lymphocyte ratio (NLR), derived NLR (dNLR), platelet to lymphocyte ratio (PLR), mean platelet volume to platelet ratio (MPR), neutrophil to lymphocyte × platelet ratio (NLPR), monocyte to lymphocyte ratio (MLR), systemic inflammation response index (SIRI), systemic inflammation index (SII), and the aggregate index of systemic inflammation (AISI) were calculated on hospital admission in 119 patients with laboratory confirmed COVID-19. Results. Non-survivors had significantly higher AISI, dNLR, NLPR, NLR, SII, and SIRI values when compared to survivors. Similarly, Kaplan–Meier survival curves showed significantly lower survival in patients with higher AISI, dNLR, MLR, NLPR, NLR, SII, and SIRI. However, after adjusting for confounders, only the SII remained significantly associated with survival (HR = 1.0001; 95% CI, 1.0000–1.0001, p = 0.029) in multivariate Cox regression analysis. Conclusions. The SII on admission independently predicts in-hospital mortality in COVID-19 patients and may assist with early risk stratification in this group.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30183-5 · Cited by 48,884
Clinical characteristics of coronavirus disease 2019 in China
Guan, W.-J., Ni, Z.-Y., Hu, Y., Liang, W.-H., Ou, C.-Q., He, J.-X., Liu, L., Shan, H., Lei, C.-L., Hui, D. S. C., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2002032 · Cited by 30,246
Zhou, F., Yu, T., Du, R., Fan, G., Liu, Y., Liu, Z., Xiang, J., Wang, Y., Song, B., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30566-3 · Cited by 27,263
Chen, N., Zhou, M., Dong, X., Qu, J., Gong, F., Han, Y., Qiu, Y., Wang, J., Liu, Y., Wei, Y., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30211-7 · Cited by 21,415
Wang, D., Hu, B., Hu, C., Zhu, F., Liu, X., Zhang, J., Wang, B., Xiang, H., Cheng, Z., Xiong, Y., et al. (2020) · JAMA · doi:10.1001/jama.2020.1585 · Cited by 20,148
La certeza de lo impredecible: Cultura Educación y Sociedad en tiempos de COVID19
Martínez González, M. (2020) · DSPACE System - Metalibrary (University of the Coast) · Cited by 18,463
Wu, Z., & McGoogan, J. M. (2020) · JAMA · doi:10.1001/jama.2020.2648 · Cited by 17,016
Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia
Li, Q., Guan, X., Wu, P., Wang, X., Zhou, L., Tong, Y., Ren, R., Leung, K. S. M., Lau, E. H. Y., Wong, J. Y., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2001316 · Cited by 16,575
Lu, R., Zhao, X., Li, J., Niu, P., Yang, B., Wu, H., Wang, W., Song, H., Huang, B., Zhu, N., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30251-8 · Cited by 11,907
Yang, X., Yu, Y., Xu, J., Shu, H., Xia, J., Liu, H., Wu, Y., Zhang, L., Yu, Z., Fang, M., et al. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(20)30079-5 · Cited by 10,066
Clinical, laboratory and imaging features of COVID-19: A systematic review and meta-analysis
Rodriguez-Morales, A. J., Cardona-Ospina, J. A., Gutiérrez-Ocampo, E., Villamizar-Peña, R., Holguin-Rivera, Y., Escalera-Antezana, J. P., Alvarado-Arnez, L. E., Bonilla-Aldana, D. K., Franco-Paredes, C., Henao-Martinez, A. F., et al. (2020) · Travel Medicine and Infectious Disease · doi:10.1016/j.tmaid.2020.101623 · Cited by 2,542
Hu, B., Yang, X.-R., Xu, Y., Sun, Y.-F., Sun, C., Guo, W., Zhang, X., Wang, W.-M., Qiu, S.-J., Zhou, J., et al. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-0442 · Cited by 2,493
Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan
Li, X., Xu, S., Yu, M., Wang, K., Tao, Y., Zhou, Y., Shi, J., Zhou, M., Wu, B., Yang, Z., et al. (2020) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2020.04.006 · Cited by 2,219
Hematological findings and complications of COVID‐19
Terpos, E., Ntanasis‐Stathopoulos, I., Elalamy, I., Kastritis, E., Sergentanis, T. N., Politou, M., Psaltopoulou, T., Gerotziafas, G., & Dimopoulos, M. A. (2020) · American Journal of Hematology · doi:10.1002/ajh.25829 · Cited by 1,673
The diagnostic and predictive role of NLR, d-NLR and PLR in COVID-19 patients
Yang, A.-P., Liu, J.-P., Tao, W.-Q., & Li, H.-M. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.106504 · Cited by 1,138
Coronavirus disease 2019: What we know?
He, F., Deng, Y., & Li, W. (2020) · Journal of Medical Virology · doi:10.1002/jmv.25766 · Cited by 1,007
COVID-ICU Group on behalf of the REVA Network and the COVID-ICU Investigators (2021) · Intensive Care Medicine · doi:10.1007/s00134-020-06294-x · Cited by 924
Platelet‐to‐lymphocyte ratio is associated with prognosis in patients with coronavirus disease‐19
Qu, R., Ling, Y., Zhang, Y., Wei, L., Chen, X., Li, X., Liu, X., Liu, H., Guo, Z., Ren, H., et al. (2020) · Journal of Medical Virology · doi:10.1002/jmv.25767 · Cited by 580
Sun, P., Qie, S., Liu, Z., Ren, J., Li, K., & Xi, J. (2020) · Journal of Medical Virology · doi:10.1002/jmv.25735 · Cited by 523
Gong, J., Ou, J., Qiu, X., Jie, Y., Chen, Y., Yuan, L., Cao, J., Tan, M., Xu, W., Zheng, F., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa443 · Cited by 513
Organ-specific manifestations of COVID-19 infection
Gavriatopoulou, M., Korompoki, E., Fotiou, D., Ntanasis-Stathopoulos, I., Psaltopoulou, T., Kastritis, E., Terpos, E., & Dimopoulos, M. A. (2020) · Clinical and Experimental Medicine · doi:10.1007/s10238-020-00648-x · Cited by 502
Hong, X., Cui, B., Wang, M., Yang, Z., Wang, L., & Xu, Q. (2015) · The Tohoku Journal of Experimental Medicine · doi:10.1620/tjem.236.297 · Cited by 326
The value of clinical parameters in predicting the severity of COVID‐19
Shang, W., Dong, J., Ren, Y., Tian, M., Li, W., Hu, J., & Li, Y. (2020) · Journal of Medical Virology · doi:10.1002/jmv.26031 · Cited by 270
Predicting Disease Severity and Outcome in COVID-19 Patients: A Review of Multiple Biomarkers
Tjendra, Y., Al Mana, A. F., Espejo, A. P., Akgun, Y., Millan, N. C., Gomez-Fernandez, C., & Cray, C. (2020) · Archives of Pathology & Laboratory Medicine · doi:10.5858/arpa.2020-0471-sa · Cited by 264
Neutrophils and Neutrophil Extracellular Traps Drive Necroinflammation in COVID-19
Tomar, B., Anders, H.-J., Desai, J., & Mulay, S. R. (2020) · Cells · doi:10.3390/cells9061383 · Cited by 263
Use of Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios in COVID-19
Chan, A. S., & Rout, A. (2020) · Journal of Clinical Medicine Research · doi:10.14740/jocmr4240 · Cited by 233
Risk factors associated with disease severity and length of hospital stay in COVID-19 patients
Liu, X., Zhou, H., Zhou, Y., Wu, X., Zhao, Y., Lu, Y., Tan, W., Yuan, M., Ding, X., Zou, J., et al. (2020) · Journal of Infection · doi:10.1016/j.jinf.2020.04.008 · Cited by 219
Higher level of neutrophil-to-lymphocyte is associated with severe COVID-19
Kong, M., Zhang, H., Cao, X., Mao, X., & Lu, Z. (2020) · Epidemiology and Infection · doi:10.1017/s0950268820001557 · Cited by 173
Role of Hematological Parameters in Covid-19 Patients in the Emergency Room
Usul, E., Şan, İ., Bekgöz, B., & Şahin, A. (2020) · Biomarkers in Medicine · doi:10.2217/bmm-2020-0317 · Cited by 162
Neutrophil-to-Lymphocyte Ratio and Outcomes in Louisiana COVID-19 Patients
Tatum, D. M., Taghavi, S., Houghton, A., Stover, J. R., Toraih, E. A., & Duchesne, J. C. (2020) · Shock · doi:10.1097/shk.0000000000001585 · Cited by 154
Colaneri, M., Sacchi, P., Zuccaro, V., Biscarini, S., Sachs, M., Roda, S., Pieri, T. C., Valsecchi, P., Piralla, A., Seminari, E. M., et al. (2020) · Eurosurveillance · doi:10.2807/1560-7917.es.2020.25.16.2000460 · Cited by 138
Risk factors for death in 1859 subjects with COVID-19
Chen, L., Yu, J., He, W., Chen, L., Yuan, G., Dong, F., Chen, W., Cao, Y., Yang, J., Cai, L., et al. (2020) · Leukemia · doi:10.1038/s41375-020-0911-0 · Cited by 134
Peng, J., Qi, D., Yuan, G., Deng, X., Mei, Y., Feng, L., & Wang, D. (2020) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.23475 · Cited by 129
Paliogiannis, P., Satta, R. R., Deligia, G., Farina, G., Bassu, S., Mangoni, A. A., Carru, C., & Zinellu, A. (2018) · Clinical and Experimental Medicine · doi:10.1007/s10238-018-0538-x · Cited by 123
Self-citationBlood Cell Count Derived Inflammation Indexes in Patients with Idiopathic Pulmonary Fibrosis
Zinellu, A., Paliogiannis, P., Sotgiu, E., Mellino, S., Mangoni, A. A., Zinellu, E., Negri, S., Collu, C., Pintus, G., Serra, A., et al. (2020) · Lung · doi:10.1007/s00408-020-00386-7 · Cited by 108
Self-citationDong, M., Shi, Y., Yang, J., Zhou, Q., Lian, Y., Wang, D., Ma, T., Zhang, Y., Mi, Y., Gu, X., et al. (2020) · Therapeutic Advances in Medical Oncology · doi:10.1177/1758835920937425 · Cited by 100
Predictors of progression from moderate to severe coronavirus disease 2019: a retrospective cohort
Cheng, B., Hu, J., Zuo, X., Chen, J., Li, X., Chen, Y., Yang, G., Shi, X., & Deng, A. (2020) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2020.06.033 · Cited by 91
Putzu, C., Cortinovis, D. L., Colonese, F., Canova, S., Carru, C., Zinellu, A., & Paliogiannis, P. (2018) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-018-2182-4 · Cited by 83
Self-citationThe characteristics and outcomes of 681 severe cases with COVID-19 in China
Chen, F.-F., Zhong, M., Liu, Y., Zhang, Y., Zhang, K., Su, D.-Z., Meng, X., & Zhang, Y. (2020) · Journal of Critical Care · doi:10.1016/j.jcrc.2020.07.003 · Cited by 77
Paliogiannis, P., Fois, A. G., Sotgia, S., Mangoni, A. A., Zinellu, E., Pirina, P., Carru, C., & Zinellu, A. (2018) · European Journal of Clinical Investigation · doi:10.1111/eci.12984 · Cited by 68
Self-citationPaliogiannis, P., Zinellu, A., Scano, V., Mulas, G., RIU, G. D., Pascale, R. M., Arru, L. B., Carru, C., Pirina, P., Mangoni, A. A., et al. (2020) · The Journal of Infection in Developing Countries · doi:10.3855/jidc.12879 · Cited by 66
Self-citationClinical and hematological characteristics of 88 patients with COVID‐19
Zhang, H., Cao, X., Kong, M., Mao, X., Huang, L., He, P., Pan, S., Li, J., & Lu, Z. (2020) · International Journal of Laboratory Hematology · doi:10.1111/ijlh.13291 · Cited by 65
Rokni, M., Ahmadikia, K., Asghari, S., Mashaei, S., & Hassanali, F. (2020) · BMC Infectious Diseases · doi:10.1186/s12879-020-05540-3 · Cited by 58
The timeline and risk factors of clinical progression of COVID-19 in Shenzhen, China
Wang, F., Qu, M., Zhou, X., Zhao, K., Lai, C., Tang, Q., Xian, W., Chen, R., Li, X., Li, Z., et al. (2020) · Journal of Translational Medicine · doi:10.1186/s12967-020-02423-8 · Cited by 55
Derivation and Validation of a Predictive Score for Disease Worsening in Patients with COVID-19
Gerotziafas, G., Sergentanis, T. Ν., Voiriot, G., Lassel, L., Papageorgiou, C., Elabbadi, A., Turpin, M., Dreden, P. V., Papageorgiou, L., Ψαλτοπούλου, Θ., et al. (2020) · Thrombosis and Haemostasis · doi:10.1055/s-0040-1716544 · Cited by 46
Hirahara, N., Matsubara, T., Fujii, Y., Kaji, S., Kawabata, Y., Hyakudomi, R., Yamamoto, T., Taniura, T., & Tajima, Y. (2020) · Oncotarget · doi:10.18632/oncotarget.27653 · Cited by 34
Labenz, C., Toenges, G., Wörns, M., Sprinzl, M. F., Galle, P. R., & Schattenberg, J. M. (2020) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000001827 · Cited by 23
Evaluation of antiviral therapies for coronavirus disease 2019 pneumonia in Shanghai, China
Shi, X., Lu, Y., Li, R., Tang, Y., Shi, N., Song, F., Shan, F., Chen, G., Song, P., & Shi, Y. (2020) · Journal of Medical Virology · doi:10.1002/jmv.25893 · Cited by 21
Cited by
Buonacera, A., Stancanelli, B., Colaci, M., & Malatino, L. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23073636 · Cited by 1,083
Novel Systemic Inflammation Markers to Predict COVID-19 Prognosis
Karimi, A., Shobeiri, P., Kulasinghe, A., & Rezaei, N. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.741061 · Cited by 171
Salman, E., Çelikbilek, N., Aydoğan, S., Özdem, B., Gökay, S., Kırca, F., Toyran, A., Bilici Salman, R., & Dinç, B. (2021) · Mikrobiyoloji Bulteni · doi:10.5578/mb.20219706 · Cited by 15
Metadata
- Authors
- Fois, A. G., Paliogiannis, P., Scano, V., Cau, S., Babudieri, S., Perra, R., Ruzzittu, G., Zinellu, E., Pirina, P., Carru, C., Arru, L. B., Fancellu, A., Mondoni, M., Mangoni, A. A., & Zinellu, A.
- Venue
- Molecules
- Publisher
- MDPI AG
- Published
- 2020-12-04
- Volume
- 25
- Issue
- 23
- Pages
- 5725
- ISSN
- 1420-3049 (ISSN-L)
- OpenAlex
- W3107536196
- Cited by
- 349
- References
- 48
- FWCI
- 14.92
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.